Literature DB >> 20154079

Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial.

Muzaffer Metintas1, Guntulu Ak, Emine Dundar, Huseyin Yildirim, Ragip Ozkan, Emel Kurt, Sinan Erginel, Fusun Alatas, Selma Metintas.   

Abstract

BACKGROUND: In cases of pleural effusion, tissue samples can be obtained through Abrams needle pleural biopsy (ANPB), thoracoscopy, or cutting-needle pleural biopsy under the guidance of CT scan (CT-CNPB) for histopathologic analysis. This study aimed to compare the diagnostic efficiency and reliability of ANPB under CT scan guidance (CT-ANPB) with that of medical thoracoscopy in patients with pleural effusion.
METHODS: Between January 2006 and January 2008, 124 patients with exudative pleural effusion that could not be diagnosed by cytologic analysis were included in the study. All patients were randomized after the CT scan was performed. Patients either underwent CT-ANPB or thoracoscopy. The two groups were compared in terms of diagnostic sensitivity and complications associated with the methods used.
RESULTS: Of the 124 patients, malignant mesothelioma was diagnosed in 33, metastatic pleural disease in 47, benign pleural disease in 42, and two were of indeterminate origin. In the CT-ANPB group, the diagnostic sensitivity was 87.5%, as compared with 94.1% in the thoracoscopy group; the difference was not statistically significant (P = .252). No difference was identified between the sensitivities of the two methods based on the cause, the CT scan findings, and the degree of pleural thickening. Complication rates were low and acceptable.
CONCLUSION: We recommend the use of CT-ANPB as the primary method of diagnosis in patients with pleural thickening or lesions observed by CT scan. In patients with only pleural fluid appearance on CT scan and in those who may have benign pleural pathologies other than TB, the primary method of diagnosis should be medical thoracoscopy. TRIAL REGISTRATION: clinicaltrials.gov; Identifier: NCT00720954.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20154079     DOI: 10.1378/chest.09-0884

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  35 in total

Review 1.  Medical thoracoscopy in China-the present status and the future.

Authors:  Jing-Yuan Liu; Liang Xiong; Min Zhang; Shi-Yuan Shuai; Xiao-Shan Wei; Lin-Lin Ye; Qiong Zhou
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

Review 2.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

Review 3.  Current best practice in the evaluation and management of malignant pleural effusions.

Authors:  Steven Walker; Anna C Bibby; Nick A Maskell
Journal:  Ther Adv Respir Dis       Date:  2016-10-24       Impact factor: 4.031

Review 4.  Contemporary approach to the patient with malignant pleural effusion complicating lung cancer.

Authors:  Oleg Epelbaum; Najib M Rahman
Journal:  Ann Transl Med       Date:  2019-08

Review 5.  Medical thoracoscopy and its evolving role in the diagnosis and treatment of pleural disease.

Authors:  Vivek Murthy; Jamie L Bessich
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

6.  Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA.

Authors:  Rosa Filiberti; Stefano Parodi; Roberta Libener; Giovanni Paolo Ivaldi; Pier Aldo Canessa; Donatella Ugolini; Barbara Bobbio; Paola Marroni
Journal:  Med Oncol       Date:  2013-03-27       Impact factor: 3.064

7.  Myelomatous pleural effusion as an initial sign of multiple myeloma-a case report and review of literature.

Authors:  Li-Li Zhang; Yuan-Yuan Li; Cheng-Ping Hu; Hua-Ping Yang
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

Review 8.  Pleural controversies: image guided biopsy vs. thoracoscopy for undiagnosed pleural effusions?

Authors:  Giles Dixon; Duneesha de Fonseka; Nick Maskell
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

9.  Medical Thoracoscopy vs Closed Pleural Biopsy in Pleural Effusions: A Randomized Controlled Study.

Authors:  Nithya Haridas; Suraj K P; Rajagopal T P; James P T; Ravindran Chetambath
Journal:  J Clin Diagn Res       Date:  2014-05-15

10.  Diagnostic value of medical thoracoscopy in malignant pleural effusion induced by non-Hodgkin's lymphoma.

Authors:  Zhen Wang; Yan-Bing Wu; Li-Li Xu; Mu-Lan Jin; Xiao-Li Diao; Xiao-Juan Wang; Zhao-Hui Tong; Huan-Zhong Shi
Journal:  Oncol Lett       Date:  2017-10-19       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.